AGTR1 and kidney disorder: Our previous data demonstrated TRPC5 expression and activity in mouse kidney tissues as well as rat glomeruli, and that a TRPC5-specific small-molecule inhibitor AC1903, can rescue podocytes and attenuate the progression of kidney diseases in angiotensin II type 1 receptor transgenic, and spontaneous hypertensive rat models (16, 35).